[Skip to Content]
Menu
  • ASDP Home
The American Society of Dermatopathology logo

The American Society of Dermatopathology

  • Home
  • ASDP Case Study Submission Gallery
  • 17-month-old male with multiple subcutaneous nodules and pancytopenia

Interactive Case Study - September 2026

17-month-old male with multiple subcutaneous nodules and pancytopenia
Angela M. B. Collie, MD, PhD Senior Associate Consultant
Kathryn E. Yunk Undergraduate Student
 
 
 
A 17-month-old previously healthy male presented with a three-month history of fluctuating, firm, nontender subcutaneous nodules as well as splenomegaly and low-grade fevers. Laboratory analysis revealed pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and elevated ferritin. A punch biopsy of the left lower back was performed.
Click here to view the virtual slide
Click here to view the virtual slide #2
Click here to view the virtual slide #3
Figure 1. H&E
Figure 1. H&E
Figure 2. H&E
Figure 2. H&E
Figure 3. CD3
Figure 3. CD3
Figure 4. CD8
Figure 4. CD8
Figure 5. TIA1
Figure 5. TIA1
Figure 6. TCR-betaF1
Figure 6. TCR-betaF1
Figure 7. TCR-delta
Figure 7. TCR-delta
Figure 8. TRBC1 (green) /CD3 (purple) Dual Immunohistochemical Stain
Figure 8. TRBC1 (green) /CD3 (purple) Dual Immunohistochemical Stain
Figure 9. Ki-67
Figure 9. Ki-67
Figure 10. Epstein-Barr virus encoded RNA in situ hybridization (EBER ISH)
Figure 10.  Epstein-Barr virus encoded RNA in situ hybridization (EBER ISH)
Which of the following is the best diagnosis?
Erythema nodosum
Extranodal NK/T-cell lymphoma
Lupus panniculitis
Primary cutaneous gamma-delta lymphoma
Subcutaneous panniculitis-like T-cell lymphoma
What immunohistochemical staining pattern is characteristic for the lymphocytes of subcutaneous panniculitis-like T-cell lymphoma?
CD3-positive, CD4-positive, CD8-negative, TIA-1-positive, TCR-betaF1-positive
CD3-positive, CD4-positive, CD8-negative, TIA-1-positive, TCR-betaF1-negative
CD3-positive, CD4-positive, CD8-positive, TIA-1-positive, TCR-betaF1-positive
CD3-positive, CD4-negative, CD8-positive, TIA-1-positive, TCR-betaF1-positive
CD3-positive, CD4-negative, CD8-positive, TIA-1-positive, TCR-betaF1-negative
  1. 1.  Patterson JW. Weedon's Skin Pathology. 6th ed. Philadephia: Elsevier; 2025.

  2. 2.  Arber DA BM, Cook JR, et al. The international consensus classification of myeloid and lymphoid neoplasms. Philadelphia: Wolters Kluwer; 2025.

  3. 3.  World Health Organization. Haematolymphoid tumours. 5th edition. ed. Lyon: International Agency for Research on Cancer; 2024.

  4. 4.  Goodlad JR. Updated Classification of Cutaneous Lymphoma. Adv Anat Pathol. 2025;32(3):239-255.

  5. 5.  Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845.

  6. 6.  Michonneau D, Petrella T, Ortonne N, et al. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy. Acta Derm Venereol. 2017;97(3):358-364.

  7. 7.  Gayden T, Sepulveda FE, Khuong-Quang DA, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018;50(12):1650-1657.

  8. 8.  Polprasert C, Takeuchi Y, Kakiuchi N, et al. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv. 2019;3(4):588-595.

  9. 9.  Sonigo G, Battistella M, Beylot-Barry M, et al. HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. Blood. 2020;135(13):1058-1061.

  10. 10.  Koh J, Jang I, Mun S, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021;5(20):3919-3930.

  11. 11.  Moonla C, Polprasert C, Komvilaisak P, et al. Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis. Haematologica. 2023;108(10):2743-2752.

  12. 12.  Li Z, Lu L, Zhou Z, et al. Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma. Br J Haematol. 2018;181(3):406-410.

 

Acknowledgements

 

Author Profiles

Angela M. B. Collie, MD, PhD

Mayo Clinic

Angela Collie is a hematopathologist at Mayo Clinic in Rochester, Minnesota. She attended the University of Washington for her M.D. and Ph.D. as a part of the Medical Scientist Training Program before completing AP/CP residency, hematopathology fellowship and dermatopathology fellowship at Cleveland Clinic. With her subspecialty training in both dermatopathology and hematopathology, she has a particular interest in lymphoma and all types of cutaneous hematopoietic disorders.

 

Kathryn E. Yunk

Denison University

K. Emily Yunk is an undergraduate student at Denison University. She is studying biochemistry on the pre-medicine path. Emily is interested in dermatology and pathology and learning more about both fields.

 

 

 

 

 

 

 

 

Question:

 

 

 

 
 

17-month-old male with multiple subcutaneous nodules and pancytopenia

Category

Tumors > Lymphomatous/Leukemic Infiltrates

Description

HOME CASE STUDY OF THE MONTH

The American Society of
Dermatopathology (ASDP)
2515 Waukegan Rd. #210
Bannockburn, IL 60015 USA
Phone: +1-847 572-2188

www.asdp.org
info@asdp.org